Ardelyx Inc (ARDX)

Apr 25, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 25, 2025

Apr 24, 2025

Ardelyx Announces Three Abstracts Accepted For Poster Presentations At Digestive Disease Week 2025 Conference - marketscreener.com

Apr 24, 2025

Apr 24, 2025

Ardelyx Announces Three Abstracts Accepted for Poster Presentations at Digestive Disease Week 2025 Conference - The Manila Times

Apr 24, 2025

Apr 24, 2025

Groundbreaking IBSRELA Pediatric Safety Data Headlines 3 New Studies at Digestive Disease Week 2025 - Stock Titan

Apr 24, 2025

Apr 23, 2025

(ARDX) Proactive Strategies - news.stocktradersdaily.com

Apr 23, 2025

Apr 19, 2025

Lobbying Update: $620,000 of ARDELYX INC. lobbying was just disclosed - Nasdaq

Apr 19, 2025

Apr 17, 2025

Ardelyx to Report First Quarter 2025 Financial Results on May 1, 2025 - The Manila Times

Apr 17, 2025

Apr 17, 2025

Ardelyx to Report First Quarter 2025 Financial Results on May 1, 2025 | ARDX Stock News - GuruFocus

Apr 17, 2025

Apr 17, 2025

Ardelyx, Inc. Schedules Conference Call to Discuss Q1 2025 Financial Results and Business Update - Nasdaq

Apr 17, 2025

Apr 16, 2025

Is Ardelyx Inc. (NASDAQ:ARDX) the Best Biotech Penny Stock to Buy According to Hedge Funds? - Insider Monkey

Apr 16, 2025

Apr 16, 2025

April 2025's Top Penny Stocks To Watch - Yahoo Finance

Apr 16, 2025

Apr 15, 2025

13 Best Biotech Penny Stocks to Buy According to Hedge Funds - Insider Monkey

Apr 15, 2025

Apr 15, 2025

Stride Announces Date for Third Quarter Fiscal Year 2025 Earnings Call - The Globe and Mail

Apr 15, 2025

Apr 11, 2025

Post-Hoc Analysis of the OPTIMIZE Study Supporting XPHOZAH® (tenapanor) to be Presented at the National Kidney Foundation Spring Clinical Meetings - The Manila Times

Apr 11, 2025

Apr 10, 2025

Ardelyx reveals new findings on CKD treatment XPHOZAH at NKF event - Investing.com Canada

Apr 10, 2025

Apr 10, 2025

Ardelyx reveals new findings on CKD treatment XPHOZAH at NKF event By Investing.com - Investing.com South Africa

Apr 10, 2025

Apr 10, 2025

Ontario Teachers' Appoints Terry Hickey as Chief Technology Officer - The Globe and Mail

Apr 10, 2025

Apr 10, 2025

Class Action Filed Against Ardelyx, Inc. (ARDX) Seeking Recovery for InvestorsContact Levi & Korsinsky - ACCESS Newswire

Apr 10, 2025

Apr 10, 2025

ARDX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Ardelyx, Inc. Investors Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Apr 10, 2025

Apr 10, 2025

Breakthrough: New Analysis Reveals Better Outcomes for First-in-Class Kidney Drug XPHOZAH - Stock Titan

Apr 10, 2025

Apr 08, 2025

Ardelyx CEO Michael Raab sells $191k in stock - Investing.com

Apr 08, 2025

Apr 08, 2025

Ardelyx CEO Michael Raab sells $191k in stock By Investing.com - Investing.com UK

Apr 08, 2025

Apr 07, 2025

Ardelyx stock hits 52-week low at $4.29 amid challenges By Investing.com - Investing.com South Africa

Apr 07, 2025

Apr 07, 2025

Ardelyx stock hits 52-week low at $4.29 amid challenges - Investing.com Australia

Apr 07, 2025

Apr 06, 2025

How To Trade (ARDX) - news.stocktradersdaily.com

Apr 06, 2025

Apr 06, 2025

Levi's (LEVI) Reports Q1: Everything You Need To Know Ahead Of Earnings - The Globe and Mail

Apr 06, 2025

Apr 03, 2025

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 15, 2024 in Ardelyx, Inc. LawsuitARDX - ACCESS Newswire

Apr 03, 2025

Apr 02, 2025

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 15, 2024 in Ardelyx LawsuitARDX - ACCESS Newswire

Apr 02, 2025

Apr 01, 2025

Ardelyx to Share a Post-Hoc Analysis of the OPTIMIZE Study Supporting XPHOZAH® (tenapanor) at the National Kidney Foundation Spring Clinical Meetings - The Manila Times

Apr 01, 2025

Mar 31, 2025

First-in-Class Kidney Disease Drug XPHOZAH Reveals Breakthrough Clinical Results - Stock Titan

Mar 31, 2025

Mar 31, 2025

Commit To Purchase Ardelyx At $4, Earn 20.5% Annualized Using Options - Nasdaq

Mar 31, 2025

Mar 28, 2025

Institutional owners may take dramatic actions as Ardelyx, Inc.'s (NASDAQ:ARDX) recent 6.4% drop adds to one-year losses - simplywall.st

Mar 28, 2025

Mar 27, 2025

How to Take Advantage of moves in (ARDX) - news.stocktradersdaily.com

Mar 27, 2025

Mar 25, 2025

Shareholders that lost money on Ardelyx, Inc.(ARDX) should contact Levi & Korsinsky about pending Class ActionARDX - ACCESS Newswire

Mar 25, 2025

Mar 20, 2025

Ardelyx Requests to Dismiss Class Action Filed by Investors - TradingView

Mar 20, 2025

Mar 20, 2025

DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ardelyx - Marketscreener.com

Mar 20, 2025

Mar 19, 2025

ARDELYX INC- The GF Score's 5 Key Aspects of Analysis - GuruFocus.com

Mar 19, 2025

Mar 17, 2025

Trading (ARDX) With Integrated Risk Controls - news.stocktradersdaily.com

Mar 17, 2025

Mar 13, 2025

Ardelyx honors inaugural Derek Forfang award winners By Investing.com - Investing.com Australia

Mar 13, 2025

Mar 13, 2025

Ardelyx at Barclays Conference: Pipeline Expansion and Revenue Growth - Investing.com

Mar 13, 2025

Mar 13, 2025

Ardelyx at Barclays Conference: Pipeline Expansion and Revenue Growth By Investing.com - Investing.com UK

Mar 13, 2025

Mar 13, 2025

Ardelyx honors inaugural Derek Forfang award winners - Investing.com India

Mar 13, 2025